RiVive ® Naloxone HCl Nasal Spray 3 mg Emergency Treatment of Opioid Overdose

Label at a glance#

Contacts and useful links#

PhoneLabel contact(888)-412-7454

Websitewww.rivive.comwww.RiVive.com

Label contents#

Full prescribing information#

Active ingredient (in each spray)

OTC - ACTIVE INGREDIENT SECTION

Naloxone hydrochloride 3 mg

Purpose

OTC - PURPOSE SECTION

Emergency treatment of opioid overdose

Uses

INDICATIONS & USAGE SECTION

• to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin
• this medicine can save a life

Directions

DOSAGE & ADMINISTRATION SECTION

Step 1	Step 1: CHECK if you suspect an overdose CHECK for a suspected overdose: the person will not wake up or is very sleepy or not breathing well Yell “Wake up!” Shake the person gently If the person is not awake, go to Step 2
Step 2	Step 2: GIVE 1st dose in the nose Hold nasal spray device with thumb on plunger and a finger on each side of the nozzle Insert nozzle into one nostril and press plunger firmly Each nasal spray device contains only one dose of naloxone
Step 3	Step 3: CALL 911 Get medical help immediately after giving the first dose Call 911 now
Step 4	Step 4: WATCH & GIVE WAIT 2-3 minutes after the 1st dose to give the medicine time to work If the person wakes up: Go to Step 5 If the person does not wake up: • Give a second dose of medicine using a new nasal   spray device • It is safe to keep giving doses every 2-3 minutes until   the person wakes up
Step 5	Step 5: STAY STAY until ambulance arrives: even if the person wakes up GIVE another dose if the person becomes very sleepy again You may need to give all the doses in the pack

Warning

WARNINGS SECTION

When using this product some people may experience symptoms when they wake up, such as shaking, sweating, nausea, or feeling angry. This is to be expected.

Other information

OTHER SAFETY INFORMATION

• store at 20ºC to 25ºC (68ºF to 77ºF)
• do not refrigerate
• avoid excessive heat above 40ºC (104ºF)
• do not use if sealed blister package is torn or opened

Inactive ingredients

INACTIVE INGREDIENT SECTION

hydrochloric acid, purified water, sodium chloride, sodium hydroxide, trisodium citrate dihydrate

Questions?

OTC - QUESTIONS SECTION

for more information call toll-free (888)-412-7454 or go to www.RiVive.com

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RiVive^®
Naloxone HCl Nasal Spray 3 mg
 
Emergency Treatment
of Opioid Overdose
 
FOR USE IN
THE NOSE ONLY
NOZZLE
PLUNGER
EASY
TO USE
 
2-Single-Dose
Nasal Spray Devices
0.003 fl oz (0.1 mL) each
 

HARM REDUCTION
THERAPEUTICS
Distributed by Harm Reduction Therapeutics, Inc.
Bethesda, MD 20814

image-01
Label

DailyMed RxNorm Mappings#

DailyMed Pharmacologic Classes#

DailyMed Product Concepts#

DailyMed Package Descriptions#

DailyMed Billing Units#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

• RiVive
• naloxone hydrochloride
• NALOXONE
• HYDROCHLORIC ACID
• WATER
• SODIUM CHLORIDE
• SODIUM HYDROXIDE
• TRISODIUM CITRATE DIHYDRATE

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Observed Orange Book patent history#

Patent history page 1 of 2 · 46 observed states.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.